CounselingConnection
Patients with chronic lymphocytic leukemia (CLL) present with a wide range of signs and symptoms and the course of the disease is highly variable, ranging from a slow, indolent course to rapid disease progression.
CounselingConnection
When counseling patients diagnosed with acute myeloid leukemia it is important to remember to include the patient's caregivers and donors.
Hematology/Oncology Information Center
Acute myeloid leukemia (AML) progresses more rapidly than other forms of leukemia. As such, if you or your patient are concerned they may have AML it is important to educate them on the symptoms and risk factors of the disease, as well as how to detect it and what treatments it could entail.
Hematology Information Center
The investigators sought to describe HRQOL and treatment satisfaction of ibrutinib-treated patients with CLL in the real-world setting.
Hematology/Oncology Information Center, News
Chimeric antigen receptor T-cell therapy boosts a patient's own immune cells.
Hematology Information Center
Researchers evaluated response rates to azacitidine and decitabine in patients with chronic myelomonocytic leukemia according to various sets of response criteria.
Hematology/Oncology Information Center, News
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival.
Hematology Information Center
Your patients may have questions about leukemia. Help them better understand the condition by sharing this article with them.
Hematology Information Center
Relapse risk increased with cumulative granulocyte colony-stimulating factor dosage but appeared to level out at approximately 75 mg/kg to 100 mg/kg.
News, Pediatrics Information Center
For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for adverse events during premaintenance chemotherapy.
